PT 141 peptide, also called bremelanotide, is an FDA-approved injectable for low sexual desire. Learn how it works, dosing, side effects, and safety.
PT 141 peptide, known generically as bremelanotide, is a prescription drug the FDA approved in 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is given as a subcutaneous injection, usually into the abdomen or thigh, about 45 minutes before anticipated sexual activity. It is not a hormone, not a testosterone product, and not approved for men or for general libido enhancement.
What Is PT 141 Peptide?
PT 141 is a synthetic cyclic peptide that acts on melanocortin receptors in the brain. It was originally investigated as a sunless tanning agent, and researchers noticed that study participants reported increased sexual desire — an effect that became the drug's main purpose.
The FDA approved it in June 2019 under the brand name Vyleesi. It is available only by prescription and is not classified as a controlled substance under federal law.
| Attribute | Detail |
|---|---|
| Brand name | Vyleesi |
| Generic name | Bremelanotide |
| Drug class | Melanocortin receptor agonist |
| Approved use | HSDD in premenopausal women |
| Route | Subcutaneous injection |
| Standard dose | 1.75 mg |
| Onset | About 45 minutes |
| Legal status | Prescription only; not scheduled |
How PT 141 Peptide Works
Bremelanotide binds to melanocortin receptors, particularly MC4R, which are involved in appetite, mood, and sexual desire signaling in the central nervous system. It is a brain-targeted drug rather than a blood-flow drug.
That mechanism separates it from PDE5 inhibitors such as sildenafil and tadalafil, which increase circulation to the genitals. Bremelanotide works on desire pathways; PDE5 inhibitors work on vascular response.
Interest in the pt-141 peptide for men is common, but the FDA has not approved bremelanotide for erectile dysfunction or for low desire in men. An investigational pt-141 peptide nasal spray was studied in early trials, but absorption was inconsistent, and the approved product is an injection.
PT 141 Peptide Dosage, Timing, and Forms
The FDA label specifies a single 1.75 mg subcutaneous dose taken about 45 minutes before anticipated sexual activity. The label allows no more than one dose in 24 hours and no more than eight doses per month.
A pt-141 peptide dosage chart may list 1.75 mg as the standard injectable dose, and that number matches the approved label. Doses promoted by gray-market vendors often differ and are not supported by clinical data.
| Form | Typical amount | Timing | Regulatory status |
|---|---|---|---|
| Subcutaneous injection (Vyleesi) | 1.75 mg | ~45 minutes before activity | FDA-approved |
| Nasal spray | Varies by study | Not standardized | Not approved |
| Compounded or research-grade vials | Varies by seller | Not standardized | Not FDA-approved |
Two practical points matter here: food intake does not appear to change how the injection performs, and using more than the labeled amount does not reliably improve results — it mainly increases nausea.
Side Effects and Safety Considerations
Nausea is the most frequently reported side effect, affecting roughly 40 percent of participants in clinical trials. Flushing, headache, vomiting, and injection site reactions are also common.
Bremelanotide can cause a temporary rise in blood pressure along with a small drop in heart rate. It is not recommended for people with uncontrolled hypertension or known cardiovascular disease.
- Repeated use has been linked to focal melanosis — darkening of the skin, gums, or breasts.
- The drug can slow gastric emptying, which may affect how quickly oral medications are absorbed.
- It is not recommended during pregnancy and has not been studied in people under 18.
Anyone considering PT 141 should review cardiovascular history, current medications, and pregnancy plans with a healthcare professional before starting it.
Legal Status, Price, and Where to Get It
PT 141 is a prescription drug in the United States. It is not scheduled as a controlled substance, but obtaining it without a prescription is still not legal for personal use.
Searching for pt-141 peptide near me usually surfaces telemedicine platforms and compounding pharmacies rather than a retail shelf. The legitimate route is an evaluation by a licensed clinician and a prescription filled by an authorized pharmacy.
The pt-141 peptide price without insurance can exceed $1,000 per month for the branded auto-injector. Insurance coverage varies widely, and the manufacturer offers a savings program that lowers the cost for eligible patients.
Vials sold as "research-grade" PT 141 are not FDA-approved, are not verified for sterility or accurate dosing, and carry "not for human consumption" labels for a reason. Major marketplaces prohibit the sale of prescription drugs, so listings that appear on them are not the approved medication.
How PT 141 Compares to Other Options
| Option | Class | Route | Approved for | Notes |
|---|---|---|---|---|
| Bremelanotide (PT 141) | Melanocortin agonist | Injection, as needed | HSDD, premenopausal women | Acts on desire pathways in the brain |
| Flibanserin (Addyi) | Serotonin receptor modulator | Oral, daily | HSDD, premenopausal women | Taken every night, not on demand |
| Sildenafil / tadalafil | PDE5 inhibitor | Oral, as needed | Erectile dysfunction in men | Targets blood flow, not desire |
| Testosterone therapy | Hormone | Varies | Hypogonadism | Used off-label in women; different risk profile |
What Users Report
Online pt-141 peptide reviews tend to focus on two things: how quickly desire increased and how manageable the nausea was. Clinical trial averages show a modest improvement over placebo, and a meaningful share of users report little or no benefit.
Response varies widely from person to person. A drug that works well for one patient may do nothing for another, and no online review can predict individual results.
PT 141 peptide is a real, FDA-approved medication for one specific diagnosis, not a general-purpose libido enhancer. Anyone with questions about whether it fits their situation should talk with a licensed healthcare professional.
Frequently Asked Questions
Is PT 141 peptide FDA-approved?
Yes. Bremelanotide, sold as Vyleesi, was approved by the FDA in 2019 to treat hypoactive sexual desire disorder in premenopausal women. It is given as a subcutaneous injection and is not approved for men or for general libido enhancement.
How long does PT 141 take to work?
The labeled dose is 1.75 mg injected under the skin about 45 minutes before anticipated sexual activity. Effects may last a few hours, and the label allows no more than one dose in 24 hours and no more than eight doses per month.
Can you buy PT 141 peptide online without a prescription?
Products sold online as research chemicals or research-grade vials are not FDA-approved, are not verified for purity or sterility, and are not legal for human use. In the US, the only legitimate route is a prescription from a licensed clinician filled by an authorized pharmacy.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.